Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: In vitro studies in normolipidemic and dyslipidemic human plasmas
- 28 February 1999
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 88 (2) , 185-190
- https://doi.org/10.1021/js980353k
Abstract
The purpose of these studies was to determine the distribution of a lipophilic antimalarial agent, halofantrine hydrochloride (Hf), in fasted plasma from hypo-, normo-, and hyperlipidemic patients that displayed differences in lipoprotein concentration and lipid transfer protein I (LTP I) activity. To assess the influence of modified lipoprotein concentrations and LTP I activity on the plasma distribution of Hf, Hf at a concentration of 1000 ng/mL was incubated in either hypo-, normo-, or hyperlipidemic human plasma for 1 h at 37 degreesC. Following incubation, the plasma samples were separated into their lipoprotein and lipoprotein-deficient plasma (LPDP) fractions by density gradient ultracentrifugation and assayed for Hf by high-pressure liquid chromatography. The activity of LTP I in the dyslipidemic plasma samples was determined in terms of its ability to transfer cholesteryl ester from low-density lipoproteins (LDL) to high-density lipoproteins (HDL). Total plasma and lipoprotein cholesterol (esterified and unesterified), triglyceride, and protein levels in the dyslipidemic plasma samples were determined by enzymatic assays. When Hf was incubated in normolipidemic plasma for 1 h at 37 degreesC, the majority of drug was found in the LPDP fraction. When Hf was incubated in human plasma of varying total lipid, lipoprotein lipid, and protein concentrations and LTP I activity, the following relationships were observed. As the triglyceride-rich lipoprotein (TRL) lipid and protein concentration increased from hypolipidemia through to hyperlipidemia, the proportion of Hf associated with TRL increased (r > 0.90). As the HDL lipid and protein concentration increased, the proportion of Hf associated with HDL decreased (r > 0.70). As the total and lipoprotein lipid levels increased, the LTP I activity of the plasma also proportionally increased (r > 0.85). Furthermore, with the increase in LTP I activity, the proportion of Hf associated with the TRL fraction increased (r > 0.70) and the proportion of Hf associated with the HDL fraction decreased (r > 0.80). In addition, a positive correlation between the proportion of apolar lipid and Hf recovered within each lipoprotein fraction was observed within hypo- (r > 0.80), normo- (r = 0.70), and hyperlipidemic (r > 0.90) plasmas. These findings suggest that changes in the HDL and TRL lipid and protein concentrations, LTP I activity, and the proportion of apolar lipid within each lipoprotein fraction may influence the plasma lipoprotein distribution of Hf in dyslipidemia.Keywords
This publication has 15 references indexed in Scilit:
- Effect of Altered Serum Lipid Concentrations on the IC50 of Halofantrine against Plasmodium FalciparumJournal of Pharmaceutical Sciences, 1998
- Administration of Long-Term Tamoxifen Therapy Modifies the Plasma Lipoprotein—Lipid Concentration and Lipid Transfer Protein I Activity in Postmenopausal Women with Breast CancerJournal of Pharmaceutical Sciences, 1997
- Human Plasma Distribution of Free Paclitaxel and Paclitaxel Associated with Diblock CopolymersJournal of Pharmaceutical Sciences, 1997
- Distribution of Free and Liposomal Annamycin within Human Plasma Is Regulated by Plasma Triglyceride Concentrations but Not by Lipid Transfer ProteinJournal of Pharmaceutical Sciences, 1995
- A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditionsJournal of Pharmaceutical and Biomedical Analysis, 1995
- Concentrations in serum and distribution in tissue of free and liposomal amphotericin B in rats during continuous intralipid infusionAntimicrobial Agents and Chemotherapy, 1994
- Clinical Pharmacokinetics of HalofantrineClinical Pharmacokinetics, 1994
- Pharmacokinetics, Tissue Distribution, and Toxicity of Free and Liposomal Amphotericin B in Diabetic RatsThe Journal of Infectious Diseases, 1990
- Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the bloodJournal of Pharmacy and Pharmacology, 1982
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955